Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [●] ("Holder"), as registered owner of this Purchase Warrant, to Tenon Medical, Inc., a Delaware corporation (the "Company"), Holder is entitled, at any time or from time to time beginning [●], 2022 (the "Commencement Date"), and at or before 5:00 p.m., Eastern time, [●], 2026 (the "Expiration Date"), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] shares of common stock of the
...Company, par value $0.00001 per share (the "Shares"), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context.
View More
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of
[●] Aegis Capital Corp. ("Holder"), as registered owner of this Purchase Warrant, to
Tenon Medical, Citius Pharmaceuticals, Inc., a
Delaware Nevada corporation (the "Company"), Holder is entitled, at any time or from time to time
beginning [●], 2022 from [________________] [DATE THAT IS SIX MONTHS FROM THE EFFECTIVE DATE OF THE OFFERING] (the "Commencement Date"), and at or before 5:00 p.m., Eastern time,
[●], 2026 [____...________] [DATE THAT IS FIVE YEARS FROM THE EFFECTIVE DATE OF THE OFFERING] (the "Expiration Date"), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] [____] shares of common stock of the Company, par value $0.00001 $[•] per share (the "Shares"), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] $[___] per Share; Share [110% of the price of the Shares sold in the Offering]; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context.
View More
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of
[●] Aegis Capital Corp. ("Holder"), as registered owner of this Purchase Warrant, to
Tenon Medical, Inc., IEG HOLDINGS CORPORATION, a
Delaware Florida corporation (the "Company"), Holder is entitled, at any time or from time to time
beginning [●], 2022 from [________________] [DATE THAT IS ONE YEAR FROM THE EFFECTIVE DATE OF THE OFFERING] (the "Commencement Date"), and at or before 5:00 p.m., Eastern time,
[●], 2026 [___..._________] [DATE THAT IS FIVE YEARS FROM THE EFFECTIVE DATE OF THE OFFERING] (the "Expiration Date"), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] [____] shares of common stock of the Company, par value $0.00001 $0.001 per share (the "Shares"), subject to adjustment as provided in Section 6 5 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] $[___] per Share; Share [125% of the price of the Shares sold in the Offering]; provided, however, that upon the occurrence of any of the events specified in Section 6 5 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context.
View More
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of
[●] [Aegis Capital Corp./ Chardan Capital Markets, LLC] ("Holder"), as registered owner of this Purchase Warrant, to
Tenon Medical, Eyegate Pharmaceuticals, Inc., a Delaware corporation (the "Company"), Holder is entitled, at any time or from time to time
beginning [●], 2022 from [________________] [DATE THAT IS ONE YEAR FROM THE EFFECTIVE DATE OF THE OFFERING] (the "Commencement Date"), and
until at or before 5:00 p.m.,
... Eastern time, [●], 2026 [____________] [DATE THAT IS FIVE YEARS FROM THE EFFECTIVE DATE OF THE OFFERING] (the "Expiration Date"), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] [____] shares of common stock of the Company, par value $0.00001 $0.01 per share (the "Shares"), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period commencing on the Effective Date and ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] $[___] per Share; Share [125% of the price of the Company's common stock sold in the Offering or 100% of the price of the Company's common stock sold in the Offering to the Company's insiders]; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context. The term "Effective Date" shall mean [ ], the date on which the Registration Statement on Form S-1 (File No. 333-197725) of the Company was declared effective by the Securities and Exchange Commission.
View More
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of
[●] [Aegis Capital Corp./ Chardan Capital Markets, LLC] ("Holder"), as registered owner of this Purchase Warrant, to
Tenon Medical, Eyegate Pharmaceuticals, Inc., a Delaware corporation (the "Company"), Holder is entitled, at any time or from time to time
beginning [●], 2022 from [________________] [DATE THAT IS ONE YEAR FROM THE EFFECTIVE DATE OF THE OFFERING] (the "Commencement Date"), and
until at or before 5:00 p.m.,
... Eastern time, [●], 2026 [____________] [DATE THAT IS FIVE YEARS FROM THE EFFECTIVE DATE OF THE OFFERING] (the "Expiration Date"), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] [____] shares of common stock of the Company, par value $0.00001 $0.01 per share (the "Shares"), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period commencing on the Effective Date and ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] $[___] per Share; Share [125% of the price of the Company's common stock sold in the Offering]; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context. The term "Effective Date" shall mean [ ], the date on which the Registration Statement on Form S-1 (File No. 333-197725) of the Company was declared effective by the Securities and Exchange Commission.
View More
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of
[●] Laidlaw & Company (UK) Ltd. ("Holder"), as registered owner of this Purchase Warrant, to
Tenon Medical, Protea Biosciences Group, Inc., a Delaware corporation (the "Company"), Holder is entitled, at any time or from time to time
beginning [●], 2022 from [________________] [DATE THAT IS ONE YEAR FROM THE EFFECTIVE DATE] (the "Commencement Date"), and at or before 5:00 p.m., Eastern time,
[●], 2026 [____________] [DATE... THAT IS FIVE YEARS FROM THE EFFECTIVE DATE] (the "Expiration Date"), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] [____] shares [5% of the number of Firm Shares sold in the Offering] of common stock of the Company, par value $0.00001 $0.0001 per share (the "Shares"), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] $[___] per Share; Share [100% of the price of the Shares sold in the Offering]; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context. The term "Effective Date" shall mean [*], the date on which the Registration Statement on Form S-1 (File No. 333-211674) of the Company was declared effective by the Securities and Exchange Commission (the "Registration Statement").
View More
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of
[●] EF Hutton, division of Benchmark Investments, LLC ("Holder"), as registered owner of this Purchase Warrant,
to Tenon Medical, Onfolio Holdings Inc., a Delaware corporation
(collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries (the "Company"), Holder is entitled, at any time or from time to time
beginni...ng [●], from _______, 2022 [DATE THAT IS SIX MONTHS FROM THE DATE OF THE COMMENCEMENT OF SALES OF THE PUBLIC SECURITIES IN THIS INITIAL PUBLIC OFFERING] (the "Commencement Date"), and at or before 5:00 p.m., Eastern time, [●], 2026 _______, 2027 [DATE THAT IS FIVE YEARS FROM THE EFFECTIVE DATE OF THIS OFFERING] (the "Expiration Date"), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] shares of [●]1 common stock stocks of the Company, par value $0.00001 per share Company (the "Shares"), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] a price of $___ per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price of $____ per Share (equal to 110% of the initial public offering price) or the adjusted exercise price, depending on the context. The term "Effective Date" shall mean ___________, 2022, the date on which the Registration Statement on Form S-1 (File No. 333-264191) of the Company ("Registration Statement") was declared effective by the Securities and Exchange Commission (the "Commission"). This Purchase Warrant and the Shares exercisable hereby have been registered with the Commission on the Registration Statement and are thus freely tradeable.
View More
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of
[●] Aegis Capital Corp. ("Holder"), as registered owner of this Purchase Warrant, to
Tenon Medical, Inc., DarioHealth Corp., a Delaware corporation (the "Company"), Holder is entitled, at any time or from time to time
beginning [●], 2022 from [________________] [DATE THAT IS ONE YEAR FROM THE DATE OF THE UNDERWRITING AGREEMENT] (the "Commencement Date"), and at or before 5:00 p.m., Eastern time,
[●], 2026 [____________] ...[DATE THAT IS FIVE YEARS FROM THE DATE OF THE UNDERWRITING AGREEMENT] (the "Expiration Date"), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] [____] shares of common stock of the Company, par value $0.00001 $0.0001 per share (the "Shares"), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] $[___] per Share; Share [125% of the price of the Shares sold in the Offering]; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context.
View More
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of
[●] DAWSON JAMES SECURITIES, INC ("Holder"), as registered owner of this Purchase Warrant, to
Tenon Medical, InspireMD, Inc., a Delaware corporation (the "Company"), Holder is entitled, at any time or from time to time
beginning [●], 2022 from [________________] [DATE THAT IS 181 DAYS FROM THE EFFECTIVE DATE OF THE OFFERING] (the "Commencement Date"), and at or before 5:00 p.m., Eastern time,
[●], 2026 [____________] [DA...TE THAT IS FIVE YEARS FROM THE EFFECTIVE DATE OF THE OFFERING] (the "Expiration Date"), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] [____] shares of common stock of the Company, par value $0.00001 $0.0001 per share (the "Shares"), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] $[___] per Share; Share [125% of the price of the Units sold in the Offering]; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context.
View More
Purchase Warrant. THIS CERTIFIES THAT, in consideration of
funds duly paid by the payment of $100.00 and for other good and value consideration, Aegis Capital Corp. or
on behalf of [●] its assigns ("Holder"), as registered owner of this Purchase Warrant, to
Tenon Medical, NephroGenex, Inc., a Delaware corporation (the "Company"), Holder is entitled, at any time or from time to time
beginning [●], 2022 from [________________] [DATE THAT IS ONE YEAR FROM THE EFFECTIVE DATE OF THE OFFERING] (the "Commencement Date")
..., and at or before 5:00 p.m., Eastern time, [●], 2026 [____________] [DATE THAT IS FIVE YEARS FROM THE EFFECTIVE DATE OF THE OFFERING] (the "Expiration Date"), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] [____] shares of common stock of the Company, par value $0.00001 $0.001 per share (the "Shares"), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] $[___] per Share; Share [125% of the price of the Shares sold in the Offering]; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context. The term "Effective Date" shall mean the date on which the Registration Statement on Form S-1 (File No. 333-193023) of the Company was declared effective by the Securities and Exchange Commission.
View More
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of
[●] Aegis Capital Corp. ("Holder"), as registered owner of this Purchase Warrant, to
Tenon Medical, Soligenix, Inc., a Delaware corporation (the "Company"), Holder is entitled, at any time or from time to time
beginning [●], 2022 from [________________] [DATE THAT IS 180 DAYS FROM THE CLOSING DATE OF THE OFFERING] (the "Commencement Date"), and at or before 5:00 p.m., Eastern time,
[●], 2026 [____________] [DATE THAT IS ...FIVE YEARS FROM THE CLOSING DATE OF THE OFFERING] (the "Expiration Date"), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] [____] shares of the Company's common stock of the Company, stock, $0.001 par value $0.00001 per share (the "Shares"), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] $2.50 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context.
View More
